RT Journal Article
SR Electronic
T1 Metabolic syndrome and chronic diseases in COPD
JF European Respiratory Journal
JO Eur Respir J
FD European Respiratory Society
SP P2230
VO 40
IS Suppl 56
A1 Emel Bulcun
A1 Aydanur Ekici
A1 Mehmet Ekici
YR 2012
UL http://erj.ersjournals.com/content/40/Suppl_56/P2230.abstract
AB Introduction: In this study, we examined accompanying comorbidities and metabolic syndrome (MS) in patints with COPD Method: Sixty-six patients with COPD and 40 subjects as control group were included. The index severity of chronic diseases was evauated by using the MCIRS. MS was defined according to National Cholesterol Education Program.Results: MCIRS was significantly greater in patients with COPD than in control group. MS was detected in 18 patients (27.3%) in patients with COPD and in 8 patients (20 %) in control group. The rate of MS in patients with stage II COPD was higher than in in patients with stage IV COPD (p: 0.04).View this table:Table 1: The Comparison of the Rate Disorders of Metabolic Syndrome according to Stage of COPDThe MCIRS showed inverse associations with FEV1%, FVC%, FEV1/FVC% while positive association with BODE index.View this table:Table 2: The predictors of MCIRS in all subjectsConclusion: Comorbidities and MS are diseases which are seen in different form's of COPD.